News

Select Category
Wednesday 15th December 2010

University of Birmingham vaccine technology is rising star in new biotech company

Description
University of Birmingham spin-out company, Hybrid BioSystems, Ltd. (Hybrid), and Myotec Therapeutics, Ltd. (Myotec) today announced their merger to form PsiOxus Therapeutics, Ltd. (PsiOxus), a new, development stage biotechnology company using non-traditional approaches to novel therapeutics for cancer and wasting diseases.
Date:
Wednesday 15th December 2010
Categories:
Medical and Dental Sciences, Research
Displaying 13 to 13 of 13
Previous 1 2 3 4 Next